EEburyraised$700M·Growth|SStarcloudraised$200M·Growth|FFunraised$72M·Series A|SStandard Intelligenceraised$75M·Series A|NNetomiraised$110M·Series C|PParallel Web Systemsraised$100M·Series B|RRogoraised$160M·Series D|HHightouchraised$150M·Series D|TTrue Anomalyraised$650M·Series D|SSaronicraised$1.75B·Series D|AAvocaraised$125M·Series B|SSiFiveraised$400M·Series G|SSidewinder Therapeuticsraised$137M·Series B|HHermeusraised$350M·Series C|WWHOOPraised$575M·Series G|
Colossal BiosciencesCO
CO

Colossal Biosciences

Bringing extinct species back to life

Visit
AISeries CEst. 202150-200 employeesDallas

Colossal Biosciences is using CRISPR gene editing to de-extinct the woolly mammoth, thylacine (Tasmanian tiger), and dodo. Beyond de-extinction, their breakthroughs in gene editing and cold-weather biology create platform technologies for conservation and medicine.

Total Raised$225M
BOLD CapitalWinklevoss Capital

Founders

B
Ben Novak
G
George Church